COMPASS Pathways grants 21,110 options to director
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
COMPASS Pathways plc director Daphne Karydas received a grant of share options covering 21,110 ordinary shares. These options have an exercise price of $11.85 per share and were awarded at no cost as a compensation grant.
The options vest in full on the earlier of the first anniversary of the grant date or the company’s 2027 Annual General Meeting of Shareholders, and they expire in 2036. Each ordinary share may be represented by one American Depositary Share.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option (Right to Buy) | 21,110 | $0.00 | $0.00 |
Footnotes (2)
- F1. The shares underlying this option vest in full upon the earlier to occur of (i) the first anniversary of the date of grant or (ii) the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2027.
- F2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Key Figures
Key Terms
exercise price financial
vest in full financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Daphne Karydas acquire in the latest CMPS Form 4 filing?
When do Daphne Karydas’s CMPS options vest according to the Form 4?
How many derivative securities does Daphne Karydas hold after this CMPS Form 4 transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.